1. Tyrosine kinase inhibitors in sarcoma treatment (Review)
   Anastasios Kyriazoglou et al, 2022, Oncology Letters CrossRef
2. PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma
   Chenglong Chen et al, 2022, Cancer Letters CrossRef
3. Targeted therapy for osteosarcoma: a review
   Shizhe Li et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
4. Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study
   Jiaqiang Wang et al, 2023, Frontiers in Oncology CrossRef
5. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review
   Yuanrui Luo et al, 2023, Pharmaceutics CrossRef
6. Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy
   Lu Xie et al, 2023, Orthopaedic Surgery CrossRef
7. Scaffolds as Carriers of Drugs and Biological Molecules for Bone-Tissue Bioengineering
   I. A. Khlusov et al, 2022, Cell and Tissue Biology CrossRef
8. Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma
   Chenglong Chen et al, 2022, Cell Death Discovery CrossRef